Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on Sales

Anterix (ATEX) Return on Sales (2016 - 2025)

Historic Return on Sales for Anterix (ATEX) over the last 13 years, with Q4 2025 value amounting to 4.2%.

  • Anterix's Return on Sales fell 91200.0% to 4.2% in Q4 2025 from the same period last year, while for Dec 2025 it was 13.71%, marking a year-over-year increase of 187900.0%. This contributed to the annual value of 1.89% for FY2025, which is 2900.0% up from last year.
  • Anterix's Return on Sales amounted to 4.2% in Q4 2025, which was down 91200.0% from 34.49% recorded in Q3 2025.
  • In the past 5 years, Anterix's Return on Sales registered a high of 34.49% during Q3 2025, and its lowest value of 65.99% during Q2 2021.
  • For the 5-year period, Anterix's Return on Sales averaged around 11.2%, with its median value being 7.85% (2024).
  • Its Return on Sales has fluctuated over the past 5 years, first surged by 584500bps in 2023, then plummeted by -330300bps in 2024.
  • Anterix's Return on Sales (Quarter) stood at 33.03% in 2021, then soared by 58bps to 13.88% in 2022, then surged by 102bps to 0.26% in 2023, then soared by 1808bps to 4.92% in 2024, then tumbled by -185bps to 4.2% in 2025.
  • Its Return on Sales was 4.2% in Q4 2025, compared to 34.49% in Q3 2025 and 17.76% in Q2 2025.